This guidance describes FDA’s intention regarding enforcement of these requirements for class I and unclassified devices.
This guidance also describes FDA’s direct marking compliance policy for class III, LS/LS, and class II devices that are non-sterile, that are manufactured and labeled prior to their applicable direct marking compliance date, and that remain in inventory, as well as for class I and unclassified devices that are not LS/LS devices, that are non-sterile, that are manufactured and labeled prior to September 24, 2022, and that remain in inventory.
Read more online